Tegafur-uracil

From Wikipedia, the free encyclopedia

 This article is orphaned as few or no other articles link to it.
Please help introduce links in articles on related topics. (April 2008)


Tegafur-uracil is a chemotherapy drug used in the treatment of cancer, primarily bowel cancer. It is also called UFT or UFUR.[1]

UFT is the first generation of DIF(DPD Inhibitory Flouropyrimidine)drug. UFT is an oral agent with combines uracil, a competitive inhibitor of DPD, with the 5-FU prodrug tegafur in a 4:1 molar ratio. Excess uracil competes with 5-FU for DPD, thus inhibiting 5-FU catabolism.

[edit] References

  1. ^ Tegafur-uracil (Uftoral) : Cancerbackup
 This oncology article is a stub. You can help Wikipedia by expanding it.
Tablets  This pharmacology-related article is a stub. You can help Wikipedia by expanding it.